LongevityFebruary 24, 2026·5 min read
By the CIRRUS Editorial Team — how we write and source this
NAD+ supplements: current state of the evidence
One of the most-marketed longevity supplement categories also has one of the bigger gaps between marketing claims and human trial data.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy production, and levels do measurably decline with age in various tissues — the basic biological premise behind the supplement category is well established.
Supplements like NMN and NR are precursors the body converts into NAD+, and animal studies — mice specifically — have shown some genuinely promising results on markers of aging and metabolic health, which is largely the basis for the current commercial enthusiasm.
Human trial data remains considerably more limited than the animal research, with most published human studies to date being small, short-duration, and focused on confirming the supplements raise NAD+ levels — rather than larger trials demonstrating specific long-term health or longevity outcomes in people.
The practical read at this stage: the underlying biology is genuinely interesting and worth continued research investment, but current human evidence doesn't yet support the more sweeping longevity claims found in a lot of product marketing — a gap between mechanism and proven outcome worth keeping in mind before investing heavily in any specific product.
This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.